DEANNA HUNT
Senior Director of Business Development, Analytical and Formulation Sciences
1 min read
KBI Biopharma
Jul 22, 2025, 5:52:02 PM
Speaker: Deanna Hunt, Senior Director of Business Development, Analytical and Formulation Sciences, KBI Biopharma
Duration: ~20 min
CMC development is full of risk. Developers who outsource analytical services are constantly balancing that risk with cost, quality, and speed. KBI Biopharma, recipient of the CDMO Leadership Award, helps drug sponsors reduce risk and control costs through our Analytical and Formulation Sciences team, delivering accurate results right the first time, and on time.
Learn how KBI's TIME framework transforms analytical challenges into competitive advantages through:
Interested in learning more about KBI Biopharma? Contact us today.
This informative session covers how KBI's TIME framework transforms analytical challenges into competitive advantages.
This presentation introduces the latest version of proprietary SURE CHO-M technology & an afucosylated host cell line for the generation of...
Learn how KBI Biopharma’s SUREtechnology Platform™, powered by Selexis®, combines refined project workflows to accelerate the development of complex...